by
Gus Iversen, Editor in Chief | July 02, 2025
Nanox is collaborating with Keiser University in Florida to introduce its Nanox.ARC digital tomosynthesis system into clinical training programs at the university’s Sarasota campus.
The partnership gives students, radiologic technologists, and local clinicians access to the Nanox.ARC, a 3D imaging device that uses a proprietary cold cathode X-ray source. According to the company, the system produces higher-resolution images than standard X-ray and reduces radiation exposure when compared to CT. Nanox also cites clinical findings suggesting improved sensitivity and specificity over conventional 2D X-rays.
The imaging system will be integrated into Keiser University’s radiologic technology graduate curriculum and used in live demonstrations and professional training sessions. The goal, according to the companies, is to familiarize trainees and local providers with new clinical protocols and potential applications for the technology.

Ad Statistics
Times Displayed: 44472
Times Visited: 1374 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
“This partnership is the latest validation of Nanox’s end-to-end medical imaging solution and exemplifies our mission to drive the world's transition to preventive healthcare through innovative and accessible technology,” said Erez Meltzer, CEO and acting chairman of Nanox. “Keiser University students will have a window to experience an innovative technology that delivers superior diagnostic accuracy not available in traditional X-ray.”
Keiser University, headquartered in Fort Lauderdale, operates 21 campuses across Florida and serves approximately 20,000 students. It has granted around 100,000 degrees since its founding in 1977.
The Nanox.ARC is part of Nanox’s broader platform, which includes cloud-based imaging tools and AI-based algorithms aimed at enhancing early detection and diagnosis. The Israel-based company trades on the Nasdaq under the symbol NNOX.